Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

A Simple Method to Determine the Reflex Latency During WBV

2 septembre 2013 mis à jour par: Bagcilar Training and Research Hospital

A Simple Method to Determine the Reflex Latency During Whole Body Vibration

The purpose of this study was to examine the validity of the measurement method based on observation of vibration stimulation-MUAP (motor unit action potential) (1 to 1) matching that helps to measure human WBV-induced muscular reflex latency and to compare these results with the latency determination obtained using the classical methods. The investigators' principle hypothesis is that the simple method is capable of determining the WBV induced reflex response latency as reliably as the complex methods described earlier.

To achieve this goal, the investigators have averaged the electrical responses of the soleus muscle (sEMG and multi motor unit (MMU) potential) against the vertical force data obtained during all the six vibration frequencies tested in this study. The investigators have then combined all the averaged EMG data belonging to six different vibration frequencies to generate the 'cumulative averaged' sEMG and MMU for each subject. The investigators have also obtained the standard error for the cumulative averaged records which indicated the WBV-induced muscular reflex (WBV-IMR) latency.

Aperçu de l'étude

Statut

Complété

Intervention / Traitement

Description détaillée

Subjects Five healthy volunteers will be participated in the study.

Procedures During WBV, the subjects will be asked to stand upright on a vibration platform (PowerPlate Pro5, London, United Kingdom). Their hips and knees will be in a neutral position. Subjects will be barefooted, and no sponge or foam will be placed between the vibration platform and their feet (Figure 1). The whole plate oscillates with a linear movement upward and downward. Vibration amplitude is 2.2 mm. WBV frequencies will be varied randomly to cover the following six frequencies: 25, 30, 35, 40,45 and 50 Hz. Each frequency lasts for 60 seconds and there will be a 15 seconds rest in between different frequencies.

A load sensor (FC2331-0000-2000L Compression Load Sensor, France) will be fixed on the WBV platform in order to be able to determine induced muscular response latency. Subjects will be positioned on the WBV platform such that their right heel will be placed on the load sensor.

Recordings MMUs, surface EMG (sEMG) and force recordings will be simultaneously done using the Powerlab data acquisition system (ADInstruments, Oxford, United Kingdom). A sampling frequency of 40 kiloHertz (kHz) will be used. Data will be analyzed offline using the MATLAB (R2012a 7.14.0.739).

In order to record sEMG, Ag/AgCl electrodes [KENDALL ® Arbo] with a disc radius of 10 mm will be placed 20 mm apart on the right soleus muscle belly, on shaved skin cleaned with alcohol. The ground electrode will be placed on the lateral malleolus.

To record MMU activity, a pair of Teflon® insulated silver wires (75 µm in core diameter) will be used. About 3 mm of the tips of the silver wires will be stripped of their Teflon ® coating in order to be able to record the activity of several motor units. The pair of wires will be inserted into the right soleus muscle with a 25 G needle. Needle will be immediately withdrawn leaving the fish-hooked wires in the muscle. A lip-clip electrode will be used as the ground electrode.

All cables will be carefully taped to the skin to minimize mechanical artifacts.

The subjects will be instructed to relax their muscles throughout the recordings and were trained using EMG feedback to this end. WBV may impair the sense of balance and muscles may be activated to restore balance. To overcome this issue, the subjects will be familiarized with WBV with a 15 s session of WBV, the subjects will be asked to use the handles of the WBV device to secure their balance and the base of support (distance between the heels) will be adjusted as wide. The distance between the heels usually will be about 25 cm.

Filtering and Rectification regimens All force sensor recordings will be 5 Hz high-pass filtered. All sEMG recordings will be 80 - 500 Hz band-pass filtered (Butterworth 1st order) and full-wave rectified to overcome movement artifacts. All MMU recordings will be 100-5000 Hz band-pass filtered (Butterworth 1st order) and full-wave rectified.

WBV - induced muscular reflex (WBV-IMR) latency

In a previous study, right soleus muscle sEMG measurement and force sensor measurement that is placed under right heel during WBV were taken synchronously and it was found that vibration stimulation and MUAPs would be matched 1 to 1. In this study that is based on the previous observation, it is predicted that it is possible to calculate latency by using averaging method.

All MMU and sEMG data will be analyzed by applying respectively filtering, rectification and differentiation with MATLAB (R2012a 7.14.0.739). Data analysis will be performed in two stages:

  1. Detection of the moment of mechanical stimulation threshold (Force Sensor Data Averaging): Force sensor data will be averaged by using Spike triggered averaging (STA) method. For this, 50 seconds of constant time intervals of preset vibration frequency in a WBV set will be used. All the positive peaks in both MMU and sEMG traces will be marked. For all the positive peaks, the force sensor trace will be segmented covering 75 ms previous positive peak. After, cumulative average of these 6 vibration sets will be averaged. The standard error on the cumulative averaged force records will be calculated. The lowest point of standard error on force sensor averaging graphic will be considered as the starting point of mechanical stimulation that triggers the muscle response.
  2. Determination of the MUAP onset: EMG data averaging method and manual method (vibration stimulus and MUAP coupling) will be used.

Type d'étude

Interventionnel

Inscription (Réel)

5

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • İstanbul, Turquie
        • Bağcılar Training & Research Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

20 ans à 45 ans (Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Young adult (20-45 yrs)
  • Healthy
  • Right handed

Exclusion Criteria:

  • Any health problems
  • Left handed

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Science basique
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Whole-body vibration
A new method for muscle reflex latency measurement
High amplitude whole-body vibration
Autres noms:
  • Chargement mécanique cyclique

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Délai
Latency measurement method
Délai: 1 day
1 day

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chaise d'étude: ILHAN KARACAN, MD, Bagcilar Training & Research Hospital

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 août 2013

Achèvement primaire (Réel)

1 août 2013

Achèvement de l'étude (Réel)

1 août 2013

Dates d'inscription aux études

Première soumission

18 juillet 2013

Première soumission répondant aux critères de contrôle qualité

23 juillet 2013

Première publication (Estimation)

25 juillet 2013

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

4 septembre 2013

Dernière mise à jour soumise répondant aux critères de contrôle qualité

2 septembre 2013

Dernière vérification

1 septembre 2013

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • BEAH FTR-9

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

produit fabriqué et exporté des États-Unis.

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner